Vaccination News Home Page                                            subscribe Vaccination NewsLetter

http://www.pediatrics.org/cgi/content/abstract/111/4/722

Pediatrics AAP Grand Rounds
Home Help [Feedback] [For Subscribers] [Browse & Search]


Full Text of this Article
Reprint (PDF) Version of this Article
P3Rs: Submit a response to this article
Similar articles found in:
Pediatrics Online
PubMed
PubMed Citation
Search Medline for articles by:
Fortescue, E. B. || Bates, D. W.
Alert me when:
new articles cite this article
 
Download to Citation Manager
Collections under which this article appears:
Office Practice


PEDIATRICS Vol. 111 No. 4 April 2003, pp. 722-729

 

Prioritizing Strategies for Preventing Medication Errors and Adverse Drug Events in Pediatric Inpatients

Elizabeth B. Fortescue, MD*, Rainu Kaushal, MD, MPH*,{ddagger}, Christopher P. Landrigan, MD, MPH*, Kathryn J. McKenna, MS, RN*, Margaret D. Clapp, RPh§, Frank Federico, RPh||, Donald A. Goldmann, MD* and David W. Bates, MD, MSc{ddagger}

 

* Departments of Medicine, Quality Improvement, and Risk Management, Children’s Hospital, Boston, Massachusetts
{ddagger} Division of General Internal Medicine, Brigham and Women’s Hospital, Partners HealthCare Systems, and Harvard Medical School, Boston, Massachusetts
§ Department of Pharmacy, Massachusetts General Hospital, Boston, Massachusetts
|| Risk Management Foundation, Cambridge, Massachusetts

Objectives. Medication errors in pediatric inpatients occur at similar rates as in adults but have 3 times the potential to cause harm. Error prevention strategies in this setting remain largely untested. The objective of this study was to classify the major types of medication errors in pediatric inpatients and to determine which strategies might most effectively prevent them.

Methods. A prospective cohort study was conducted of 1020 patients who were admitted to 2 academic medical centers during a 6-week period in April and May 1999. Medication errors were characterized by subtype. Physician raters evaluated error prevention strategies and identified those that might be most effective in preventing errors.

Results. Of 10 778 medication orders reviewed, 616 contained errors. Of these, 120 (19.5%) were classified as potentially harmful, including 115 potential adverse drug events (18.7%) and 5 preventable adverse drug events (0.8%). Most errors occurred at the ordering stage (74%) and involved errors in dosing (28%), route (18%), or frequency (9%). Three interventions might have prevented most potentially harmful errors: 1) computerized physician order entry with clinical decision support systems (76%); 2) ward-based clinical pharmacists (81%); and 3) improved communication among physicians, nurses, and pharmacists (86%). Interrater reliability of error prevention strategy assignment was good (agreement: 0.92; {kappa}: 0.82).

Conclusions. Of the assessed interventions, computerized physician order entry with clinical decision support systems; ward-based clinical pharmacists; and improved communication among physicians, nurses, and pharmacists had the greatest potential to reduce medication errors in pediatric inpatients. Development, implementation, and assessment of such interventions in the pediatric inpatient setting are needed.

 

Key Words: medication error • prevention strategy • pediatric inpatient

 

Abbreviations: ADE, adverse drug event • ICU, intensive care unit • CPOE, computerized physician order entry • MAR, medication administration record • CDSS, clinical decision support system

 


Received for publication Mar 21, 2002; accepted Sep 27, 2002.





 

 

[For Subscribers]
Copyright © 2003 by the American Academy of Pediatrics. [Disclaimer]

 

Vaccination News Home Page

ALL INFORMATION, DATA, AND MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR GENERAL INFORMATION PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE KNOWLEDGE OR OPINIONS OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED AS PROVIDING MEDICAL OR LEGAL ADVICE.  THE DECISION WHETHER OR NOT TO VACCINATE IS AN IMPORTANT AND COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU ALONE, IN CONSULTATION WITH YOUR HEALTH CARE PROVIDER.